United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2003_register
executive
2010-09-23
article
Anti-counterfeit Drug Initiative
Notices
D09002ee1bdeba4bb
D09002ee1bdeba565
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is announcing that it is establishing a docket to receive information and comments on the agency's initiative against counterfeit drugs. Many individuals, vendors, trade and professional associations, consumer groups, and other stakeholders have offered to assist FDA. This action is intended to ensure that there is a venue for information and comments to be submitted to the agency regarding the anti-counterfeit initiative.
68 FR 51270
https://www.govinfo.gov/app/details/FR-2003-08-26/03-21751
03-21751
fr26au03-75
4160-01-S
Docket No. 2003N-0361
https://www.govinfo.gov/app/details/FR-2003-08-26/03-21751
https://www.govinfo.gov/content/pkg/FR-2003-08-26/html/03-21751.htm
https://www.govinfo.gov/content/pkg/FR-2003-08-26/pdf/03-21751.pdf
1 p.
51270
51270
68 FR 51270
Anti-counterfeit Drug Initiative; Federal Register Vol. 68, Issue
NOTICE
03-21751
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2003-11-30
Docket No. 2003N-0361
4160-01-S
03-21751
Notice.
The Food and Drug Administration (FDA) is announcing that it is establishing a docket to receive information and comments on the agency's initiative against counterfeit drugs. Many individuals, vendors, trade and professional associations, consumer groups, and other stakeholders have offered to assist FDA. This action is intended to ensure that there is a venue for information and comments to be submitted to the agency regarding the anti-counterfeit initiative.
The agency encourages interested parties to submit information by November 30, 2003.
Poppy Kendall, Office of Policy (HF- 11), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-3360, e-mail: pkendall@fda.gov.
Reports and guidance documents; availability, etc.:
Anti-counterfeit drug initiative,
pkendall@fda.gov
http://www.fda.gov
http://www.fda.gov/dockets/ecomments
Federal Register
Vol. 68, no. 165
Office of the Federal Register, National Archives and Records Administration
2003-08-26
continuing
daily
deposited
born digital
291 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2003-08-26
P0b002ee1809e72f8
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr26au03
https://www.govinfo.gov/app/details/FR-2003-08-26
https://www.govinfo.gov/content/pkg/FR-2003-08-26/pdf/FR-2003-08-26.pdf
https://www.govinfo.gov/content/pkg/FR-2003-08-26/xml/FR-2003-08-26.xml
fdlp
51149
51428
DGPO
2010-09-23
2023-05-04
FR-2003-08-26
machine generated
eng
FR
FR-2003-08-26
68
165